Cite
HARVARD Citation
Sokolove, J. et al. (n.d.). SAT0074 Effect of Baseline Anti-Cyclic Citrullinated Peptide 2 Antibody Titre on Patient-Reported Outcomes Following Treatment with Subcutaneous Abatacept or Adalimumab. Annals of the rheumatic diseases. p. 675. [Online].